Skip to main content

Table 2 Adherence measures for SPAA and CCB+statin primary prevention patients

From: Association between adherence to calcium-channel blocker and statin medications and likelihood of cardiovascular events among US managed care enrollees

 

SPAA

CCB+Statin

 
 

(N = 1,537)

(N = 17,910)

p-value

6 Months

     

Number (%) of patients with PDC ≥80%

868

56.5%

3,825

21.4%

<.001

Mean PDC (SD)

0.73

(0.26)

0.49

(0.31)

 

Median PDC

0.83

 

0.50

 

<.001

12 Months

     

Number (%) of patients with PDC ≥ 80%

712

46.3%

3,529

19.7%

<.001

Mean PDC (SD)

0.66

(0.30)

0.46

(0.31)

 

Median PDC

0.75

 

0.46

 

<.001

18 Months

     

Number (%) of patients with PDC ≥ 80%

650

42.3%

3,342

18.7%

<.001

Mean PDC (SD)

0.62

(0.31)

0.43

(0.32)

 

Median PDC

0.72

 

0.42

 

<.001

Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us